ATE325123T1 - Imidazoquinoline derivate als adenosine a3 rezeptor liganden - Google Patents

Imidazoquinoline derivate als adenosine a3 rezeptor liganden

Info

Publication number: ATE325123T1
Authority: AT; Austria
Prior art keywords: adenosine; receptor ligands; imidazoquinoline derivatives; imidazoquinoline; derivatives
Prior art date: 2002-11-15

Application number

AT03773882T

Other languages

English (en)

Inventor

Peter Aranyi

Laszl Balazs

Maria Balogh

Sandor Batori

Nagy Lajos T

Geza Timari

Kinga Boer

Zolt N Kapui

Endre Mikus

Katalin Gerber

Szeredi Judit Vargane

Katalin Urban-Szabo

Erzsebet Walcz

Original Assignee

Sanofi Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-11-15

Filing date

2003-11-11

Publication date

2006-06-15

2003-11-11 Application filed by Sanofi Aventis filed Critical Sanofi Aventis

2006-06-15 Application granted granted Critical

2006-06-15 Publication of ATE325123T1 publication Critical patent/ATE325123T1/de

Links

RHKWIGHJGOEUSM-UHFFFAOYSA-N 3h-imidazo[4,5-h]quinoline Chemical class C1=CN=C2C(N=CN3)=C3C=CC2=C1 RHKWIGHJGOEUSM-UHFFFAOYSA-N 0.000 title 1
102000008161 Adenosine A3 Receptor Human genes 0.000 title 1
108010060261 Adenosine A3 Receptor Proteins 0.000 title 1
239000003446 ligand Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Psychiatry (AREA)
Urology & Nephrology (AREA)
Dermatology (AREA)
Immunology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Obesity (AREA)
Epidemiology (AREA)
Rheumatology (AREA)
Ophthalmology & Optometry (AREA)
Psychology (AREA)
Emergency Medicine (AREA)
Hospice & Palliative Care (AREA)
Endocrinology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Otolaryngology (AREA)
Vascular Medicine (AREA)

AT03773882T 2002-11-15 2003-11-11 Imidazoquinoline derivate als adenosine a3 rezeptor liganden ATE325123T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
HU0203976A HUP0203976A3 (en)	2002-11-15	2002-11-15	Adenozine a3 receptors, process for their preparation and pharmaceutical compositions containing them

Publications (1)

Publication Number	Publication Date
ATE325123T1 true ATE325123T1 (de)	2006-06-15

Family

ID=90001561

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03773882T ATE325123T1 (de)	2002-11-15	2003-11-11	Imidazoquinoline derivate als adenosine a3 rezeptor liganden

Country Status (34)

Country	Link
US (2)	US7419977B2 (de)
EP (1)	EP1560828B9 (de)
JP (1)	JP4533148B2 (de)
KR (1)	KR20050088291A (de)
CN (1)	CN1332960C (de)
AR (1)	AR041968A1 (de)
AT (1)	ATE325123T1 (de)
AU (1)	AU2003282263B2 (de)
BR (1)	BR0316355A (de)
CA (1)	CA2505910C (de)
CO (1)	CO5690577A2 (de)
CY (1)	CY1105180T1 (de)
DE (1)	DE60305058T2 (de)
DK (1)	DK1560828T3 (de)
EA (1)	EA007595B1 (de)
ES (1)	ES2263039T3 (de)
HR (1)	HRP20050540A2 (de)
HU (1)	HUP0203976A3 (de)
IL (1)	IL168516A (de)
IS (1)	IS2456B (de)
MA (1)	MA27501A1 (de)
ME (1)	MEP19008A (de)
MX (1)	MXPA05005198A (de)
NO (1)	NO20052866D0 (de)
NZ (1)	NZ540029A (de)
PL (1)	PL376837A1 (de)
PT (1)	PT1560828E (de)
RS (1)	RS51320B (de)
SI (1)	SI1560828T1 (de)
TN (1)	TNSN05133A1 (de)
TW (1)	TWI248934B (de)
UA (1)	UA78889C2 (de)
WO (1)	WO2004046146A1 (de)
ZA (1)	ZA200503807B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HUP0105406A3 (en) *	2001-12-21	2003-12-29	Sanofi Aventis	Imidazo[1,2-a]quinolin derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates
HUP0203976A3 (en) *	2002-11-15	2004-08-30	Sanofi Aventis	Adenozine a3 receptors, process for their preparation and pharmaceutical compositions containing them
HUP0400812A2 (en) *	2004-04-19	2006-02-28	Sanofi Aventis	Crystalline forms of 2-amino-3-cyano-quinoline derivatives, process for their preparation and pharmaceutical compositions containing them
GT200600381A (es)	2005-08-25	2007-03-28		Compuestos organicos
US20090088403A1 (en) *	2007-05-07	2009-04-02	Randy Blakely	A3 adenosine receptors as targets for the modulation of central serotonergic signaling
HUP0700395A2 (en) *	2007-06-07	2009-03-02	Sanofi Aventis	Substituted [1,2,4] triazolo [1,5-a] quinolines, process for their preparation, pharmaceutical compositions thereof, and intermediates
US9199102B2 (en)	2009-07-21	2015-12-01	Oradin Pharmaceutical Ltd.	A3 adenosine receptor ligands for modulation of pigmentation
DK2950649T3 (da)	2013-02-01	2020-05-04	Wellstat Therapeutics Corp	Aminforbindelser med antiinflammations-, antisvampe-, antiparasit- og anticanceraktivitet
KR101820909B1 (ko) *	2017-07-07	2018-01-23	퓨쳐메디신 주식회사	아데노신 유도체를 포함하는 만성신장질환 예방 및 치료용 약학적 조성물
TWI846350B (zh)	2017-09-15	2024-06-21	美商佛瑪治療公司	作為ＣＢＰ／ｐ３００抑制劑之四氫－咪唑並喹啉化合物
MX2023013508A (es)	2018-06-29	2023-12-13	Forma Therapeutics Inc	Inhibicion de la proteina de union a creb (cbp).
CN119684285A (zh) *	2019-03-15	2025-03-25	福马治疗股份有限公司	抑制环amp-应答元件结合蛋白(creb)
US12351577B2 (en)	2019-03-15	2025-07-08	Forma Therapeutics, Inc.	Inhibiting cyclic AMP-responsive element-binding protein (CREB)
US11801243B2 (en)	2020-09-23	2023-10-31	Forma Therapeutics, Inc.	Bromodomain inhibitors for androgen receptor-driven cancers
US11795168B2 (en)	2020-09-23	2023-10-24	Forma Therapeutics, Inc.	Inhibiting cyclic amp-responsive element-binding protein (CREB) binding protein (CBP)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4075343A (en) *	1976-09-13	1978-02-21	Pfizer Inc.	Anti-allergenic 5-alkoxyimidazo[1,2-A]quinoline-2-carboxylic acids and derivatives thereof
GB1596652A (en) *	1977-01-20	1981-08-26	Roussel Lab Ltd	Imidazo (1,2-a) quinoline-2-carboxylic acid and derivatives
US4644002A (en) *	1979-02-09	1987-02-17	Roussel Uclaf	Imidazo[2,1-C]quinolines, useful as antiallergic agents
SE441449B (sv) *	1979-02-09	1985-10-07	Roussel Uclaf	Heterocykliska derivat och farmaceutiska kompositioner innehallande dessa derivat
FR2448541A1 (fr) *	1979-02-09	1980-09-05	Roussel Uclaf	Nouveaux derives de l'oxoimidazoquinoxaline et leurs sels, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
CA2336967C (en) *	1998-07-10	2010-06-29	The United States Of America, Represented By The Secretary, Department Of Health And Human Services	A3 adenosine receptor antagonists
US6448253B1 (en) *	1998-09-16	2002-09-10	King Pharmaceuticals Research And Development, Inc.	Adenosine A3 receptor modulators
EP1227098B1 (de) *	1999-09-28	2004-04-28	Otsuka Pharmaceutical Factory, Inc.	Triazolpurin-derivate, medikamentzusammensetzungen, die diese enthalten und mittel, die affinität zum adenosin a3 rezeptor zeigen
US7160890B2 (en) *	1999-12-02	2007-01-09	Osi Pharmaceuticals, Inc.	Compounds specific to adenosine A3 receptor and uses thereof
EP1347980A4 (de) *	2000-12-01	2005-02-09	Osi Pharm Inc	Für adenosin-a1, -a2a- und -a3-rezeptoren spezifische verbindungen und deren verwendungen
KR100745307B1 (ko) *	2001-05-31	2007-08-01	사노피-아벤티스	아미노퀴놀린 유도체 및 아데노신 ａ３ 리간드로서의 이의 용도
HUP0105407A3 (en) *	2001-12-21	2004-04-28	Sanofi Aventis	Triazolo[1,5-a]quinolin derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates
HUP0105406A3 (en) *	2001-12-21	2003-12-29	Sanofi Aventis	Imidazo[1,2-a]quinolin derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates
HUP0203976A3 (en) *	2002-11-15	2004-08-30	Sanofi Aventis	Adenozine a3 receptors, process for their preparation and pharmaceutical compositions containing them

2002
- 2002-11-15 HU HU0203976A patent/HUP0203976A3/hu unknown
2003
- 2003-11-11 HR HR20050540A patent/HRP20050540A2/xx not_active Application Discontinuation
- 2003-11-11 EA EA200500830A patent/EA007595B1/ru unknown
- 2003-11-11 CN CNB2003801062293A patent/CN1332960C/zh not_active Expired - Fee Related
- 2003-11-11 ES ES03773882T patent/ES2263039T3/es not_active Expired - Lifetime
- 2003-11-11 PT PT03773882T patent/PT1560828E/pt unknown
- 2003-11-11 JP JP2004552920A patent/JP4533148B2/ja not_active Expired - Fee Related
- 2003-11-11 SI SI200330299T patent/SI1560828T1/sl unknown
- 2003-11-11 UA UAA200505875A patent/UA78889C2/uk unknown
- 2003-11-11 CA CA2505910A patent/CA2505910C/en not_active Expired - Fee Related
- 2003-11-11 AT AT03773882T patent/ATE325123T1/de active
- 2003-11-11 DK DK03773882T patent/DK1560828T3/da active
- 2003-11-11 DE DE60305058T patent/DE60305058T2/de not_active Expired - Lifetime
- 2003-11-11 WO PCT/HU2003/000095 patent/WO2004046146A1/en not_active Ceased
- 2003-11-11 RS YUP-2005/0364A patent/RS51320B/sr unknown
- 2003-11-11 NZ NZ540029A patent/NZ540029A/en not_active IP Right Cessation
- 2003-11-11 ME MEP-190/08A patent/MEP19008A/xx unknown
- 2003-11-11 MX MXPA05005198A patent/MXPA05005198A/es active IP Right Grant
- 2003-11-11 KR KR1020057008683A patent/KR20050088291A/ko not_active Abandoned
- 2003-11-11 AU AU2003282263A patent/AU2003282263B2/en not_active Ceased
- 2003-11-11 PL PL376837A patent/PL376837A1/pl not_active Application Discontinuation
- 2003-11-11 BR BR0316355-5A patent/BR0316355A/pt not_active IP Right Cessation
- 2003-11-11 EP EP03773882A patent/EP1560828B9/de not_active Expired - Lifetime
- 2003-11-14 TW TW092131901A patent/TWI248934B/zh not_active IP Right Cessation
- 2003-11-14 AR ARP030104200A patent/AR041968A1/es unknown
2005
- 2005-05-10 IL IL168516A patent/IL168516A/en not_active IP Right Cessation
- 2005-05-10 TN TNP2005000133A patent/TNSN05133A1/en unknown
- 2005-05-11 ZA ZA200503807A patent/ZA200503807B/en unknown
- 2005-05-16 US US11/130,429 patent/US7419977B2/en not_active Expired - Fee Related
- 2005-05-31 IS IS7874A patent/IS2456B/is unknown
- 2005-06-13 NO NO20052866A patent/NO20052866D0/no not_active Application Discontinuation
- 2005-06-13 MA MA28334A patent/MA27501A1/fr unknown
- 2005-06-14 CO CO05057645A patent/CO5690577A2/es not_active Application Discontinuation
2006
- 2006-07-28 CY CY20061101054T patent/CY1105180T1/el unknown
2008
- 2008-06-17 US US12/140,512 patent/US7709489B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US7709489B2 (en)	2010-05-04
DK1560828T3 (da)	2006-09-04
EP1560828A1 (de)	2005-08-10
CA2505910C (en)	2010-07-13
RS51320B (sr)	2010-12-31
BR0316355A (pt)	2005-09-27
CN1332960C (zh)	2007-08-22
SI1560828T1 (sl)	2006-08-31
EP1560828B1 (de)	2006-05-03
ES2263039T3 (es)	2006-12-01
AU2003282263A1 (en)	2004-06-15
TWI248934B (en)	2006-02-11
EA007595B1 (ru)	2006-12-29
CO5690577A2 (es)	2006-10-31
UA78889C2 (en)	2007-04-25
US20080255110A1 (en)	2008-10-16
MEP19008A (en)	2010-06-10
TNSN05133A1 (en)	2007-05-14
EA200500830A1 (ru)	2005-10-27
CA2505910A1 (en)	2004-06-03
MXPA05005198A (es)	2005-08-18
HRP20050540A2 (en)	2005-08-31
NO20052866L (no)	2005-06-13
CN1726213A (zh)	2006-01-25
CY1105180T1 (el)	2010-03-03
EP1560828B9 (de)	2007-02-14
RS20050364A (sr)	2007-08-03
KR20050088291A (ko)	2005-09-05
MA27501A1 (fr)	2005-08-01
TW200413369A (en)	2004-08-01
PT1560828E (pt)	2006-08-31
NZ540029A (en)	2007-01-26
IS7874A (is)	2005-05-31
JP2006515572A (ja)	2006-06-01
HK1077819A1 (en)	2006-02-24
AU2003282263B2 (en)	2009-05-14
HU0203976D0 (en)	2003-01-28
US7419977B2 (en)	2008-09-02
IS2456B (is)	2008-11-15
PL376837A1 (pl)	2006-01-09
HUP0203976A3 (en)	2004-08-30
JP4533148B2 (ja)	2010-09-01
DE60305058T2 (de)	2006-12-14
ZA200503807B (en)	2006-08-30
DE60305058D1 (de)	2006-06-08
HUP0203976A2 (hu)	2004-07-28
US20050234056A1 (en)	2005-10-20
WO2004046146A1 (en)	2004-06-03
AR041968A1 (es)	2005-06-01
NO20052866D0 (no)	2005-06-13
IL168516A (en)	2011-05-31

Legal Events

Date

Code

Title

Description

2007-03-15

UEP

Publication of translation of european patent specification

Ref document number: 1560828

Country of ref document: EP

Publication	Publication Date	Title
ATE450528T1 (de)	2009-12-15	Chinazolinderivate als antitumormittel
ATE384053T1 (de)	2008-02-15	Triazolderivate als tachykininrezeptor- antagonisten
ATE481402T1 (de)	2010-10-15	Pyrazolopyridin-derivate
ATE359275T1 (de)	2007-05-15	Substituierte bizyclische derivate verwendbar als antitumor mittel
ATE376549T1 (de)	2007-11-15	Pyrrolopyridazin derivate
ATE512965T1 (de)	2011-07-15	Pyrrolopyrimidin derivate
ATE312078T1 (de)	2005-12-15	1-aryl-oder 1-alkylsulfonylbenzazol derivate als 5-hydroxytryptamin-6 liganden
DE60331444D1 (de)	2010-04-08	1h-1,2,4- triazol-3- carboxamid derivate als cannabinoid-cb1 receptor liganden
DE602004015724D1 (de)	2008-09-25	Diazepinoindolderivate als kinaseinhibitoren
ATE340782T1 (de)	2006-10-15	Piperidinbenzolsulfonamidderivate
ATE352550T1 (de)	2007-02-15	Chinazolinderivate
ATE415400T1 (de)	2008-12-15	Pyrazolopyridinderivate
ATE452892T1 (de)	2010-01-15	Substituierte 8-perfluoro-6,7,8,9- tetrahydropyrimido-(1,2a) pyrimidin-4-on derivate
ATE395345T1 (de)	2008-05-15	Imidazol-4-yl-ethynyl-pyridin-derivate
ATE398450T1 (de)	2008-07-15	Derivate von aryl-chinazolin/aryl-2amino-phenyl- methanon zurförderung der freisetzung von parathormon
ATE306265T1 (de)	2005-10-15	Benzothiazolderivate als adenosin-rezeptor- liganden
ATE325123T1 (de)	2006-06-15	Imidazoquinoline derivate als adenosine a3 rezeptor liganden
MA28686B1 (fr)	2007-06-01	Derives de pyrrolopyridine
DE60316411D1 (de)	2007-10-31	Thiazolderivate als npy-rezeptorantagonisten
ATE377008T1 (de)	2007-11-15	Imidazolderivate als glutamatrezeptorantagonisten
ATE394372T1 (de)	2008-05-15	G-lactamderivate als prostaglandinagonisten
ATE281456T1 (de)	2004-11-15	Aminotriazolopyridinderivate als adenosinrezeptorliganden
DE60214408D1 (de)	2006-10-12	5-METHOXY-8-ARYL-i1,2,4öTRIAZOLOi1,5-AöPYRIDINE DERIVATIVE ALS ADENOSIN-REZEPTOR ANTAGONISTEN
ATE427945T1 (de)	2009-04-15	Imidazolderivate
DK1636223T3 (da)	2008-06-23	Benzothiazolderivater som adenosinreceptorligander